|
DISEASE: Cutaneous: Melanoma
Select a REGIMEN:
DBPT
DTIC1
DTIC2
VDP
DISEASE: Cutaneous: Melanoma
REGIMEN: DBPT
DACARBAZINE [DTIC] 220 mg/m2 per day
IV...D1-3
q 3 weeks
CISPLATIN [CDDP] 25 mg/m2 per day
IV...D1-3
q 3 weeks
CARMUSTINE [BCNU] 150 mg/m2 IV...D1
q 6 weeks Caution: Monitor cumulative dose (pulmonary
and marrow toxicity)
TAMOXIFEN [TAM] 10 mg PO...daily
BID
CYCLE: None
REFER: Skeel RT: Handbook of Cancer Chemotherapy, 3rd Ed.
Little, Brown & Co. 1991; 256.
DISEASE: Cutaneous: Melanoma
REGIMEN: DTIC1
DACARBAZINE [DTIC] 250 mg/m2 per day
IV...D1-5
CYCLE: 21 days
REFER: DeVita VT Jr, et al: Cancer Principles and Practice of
Oncology 3rd Ed. J.B.Lippincott Co. 1989; 1522.
DISEASE: Cutaneous: Melanoma
REGIMEN: DTIC2
DACARBAZINE [DTIC] 850 mg/m2 IV...D1
CYCLE: 21-28 days
REFER: DeVita VT Jr, et al: Cancer Principles and Practice of
Oncology 3rd Ed. J.B.Lippincott Co. 1989; 1637.
DISEASE: Cutaneous: Melanoma
REGIMEN: VDP
VINBLASTINE [VLB] 5 mg/m2 per day
IV...D1,2
DACARBAZINE [DTIC] 150 mg/m2 per day
IV...D1-10
CISPLATIN [CDDP] 75 mg/m2 IV...D5
CYCLE: 21-28 days
REFER: Nathanson L: Melanomas ... In: Skeel RT, ed. Handbook of
Cancer Chemotherapy, 3rd Ed. Little, Brown & Co. 1991; 256.
|
